ATXS – astria therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Astria Therapeutics (NASDAQ:ATXS) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Astria Stockholders Vote to Approve Acquisition by BioCryst
Halper Sadeh LLC Encourages CSGS, JHG, CWAN, ATXS Shareholders to Contact the Firm to Discuss Their Rights
Astria Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Astria Therapeutics, Inc. - ATXS
Halper Sadeh LLC Encourages ATXS, GDOT, UBFO Shareholders to Contact the Firm to Discuss Their Rights
Form 25-NSE/A Astria Therapeutics, Filed by: Nasdaq Stock Market LLC
Form S-8 POS Astria Therapeutics,
Form S-8 POS Astria Therapeutics,
Form S-8 POS Astria Therapeutics,
Form S-8 POS Astria Therapeutics,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.